BCL2L1 and head and neck squamous cell carcinoma: Upregulation of BCL-2 and BCL-XL is correlated with chemotherapy-resistance in HNSCC cells, and downregulation of these proteins by antisense or siRNA can sensitize to chemotherapy in HNSCC cells.